caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1508090754

Nicholas MitsiadesM.D., P.HD.

PRACTICEBEN TAUB GENERAL HOSPITALSee all providers at this practice →
Hematology-OncologyHouston, TXI
CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
No data available for this provider in 2024.
QUALITY · MIPS · 2024
Final MIPS score
83.2
Quality
64.8
Cost
68.7
Improvement activities
40.0
Promoting interop.
100.0
Payment adjustment
0.34%
Group
REFERRAL NETWORK

Where Nicholas Mitsiades's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 2 inbound referrers · 2 outbound destinations.

Receives referrals from
Inbound — who sends patients here
PhysicianPatientsVisits
HARRIS COUNTY HOSPITAL DISTRICT31208
Martha Mims
Hematology-Oncology · Houston, TX
2187
Refers patients to
Outbound — where patients go next
PhysicianPatientsVisits
HARRIS COUNTY HOSPITAL DISTRICT21126
Martha Mims
Hematology-Oncology · Houston, TX
1557
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
PRESCRIBING · PART D · 2024
Total Rx claims
378
Beneficiaries
—
Total drug cost
$2.7M
Distinct drugs
7
Brand share
54.0%
Top prescribed drugs
Darolutamide115 claims
Prednisone83 claims
Abiraterone Acetate64 claims
Enzalutamide45 claims
Apalutamide44 claims
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
167
Unique beneficiaries
—
Total services
371
Distinct HCPCS
5
Medicare payment
$24K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 613 Hematology-Oncology providers in TX — below median (cohort median 2,625).